289 related articles for article (PubMed ID: 33540516)
1. Protein Substitutes in PKU; Their Historical Evolution.
Daly A; Evans S; Pinto A; Ashmore C; MacDonald A
Nutrients; 2021 Feb; 13(2):. PubMed ID: 33540516
[TBL] [Abstract][Full Text] [Related]
2. Growth and Body Composition in PKU Children-A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes.
Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Strauss BJ; Wilcox G; Rocha JC; Ashmore C; MacDonald A
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33923714
[TBL] [Abstract][Full Text] [Related]
3. Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria.
Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
Nutrients; 2020 Aug; 12(8):. PubMed ID: 32823853
[TBL] [Abstract][Full Text] [Related]
4. Practices in prescribing protein substitutes for PKU in Europe: No uniformity of approach.
Aguiar A; Ahring K; Almeida MF; Assoun M; Belanger Quintana A; Bigot S; Bihet G; Blom Malmberg K; Burlina A; Bushueva T; Caris A; Chan H; Clark A; Clark S; Cochrane B; Corthouts K; Dalmau J; Dassy M; De Meyer A; Didycz B; Diels M; Dokupil K; Dubois S; Eftring K; Ekengren J; Ellerton C; Evans S; Faria A; Fischer A; Ford S; Freisinger P; Giżewska M; Gokmen-Ozel H; Gribben J; Gunden F; Heddrich-Ellerbrok M; Heiber S; Heidenborg C; Jankowski C; Janssen-Regelink R; Jones I; Jonkers C; Joerg-Streller M; Kaalund-Hansen K; Kiss E; Lammardo AM; Lang K; Lier D; Lilje R; Lowry S; Luyten K; MacDonald A; Meyer U; Moor D; Pal A; Robert M; Robertson L; Rocha JC; Rohde C; Ross K; Saruhan S; Sjöqvist E; Skeath R; Stoelen L; Ter Horst NM; Terry A; Timmer C; Tuncer N; Vande Kerckhove K; van der Ploeg L; van Rijn M; van Spronsen FJ; van Teeffelen-Heithoff A; van Wegberg A; van Wyk K; Vasconcelos C; Vitoria I; Wildgoose J; Webster D; White FJ; Zweers H
Mol Genet Metab; 2015 May; 115(1):17-22. PubMed ID: 25862610
[TBL] [Abstract][Full Text] [Related]
5. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
[TBL] [Abstract][Full Text] [Related]
6. Purification and use of glycomacropeptide for nutritional management of phenylketonuria.
Laclair CE; Ney DM; MacLeod EL; Etzel MR
J Food Sci; 2009; 74(4):E199-206. PubMed ID: 19490325
[TBL] [Abstract][Full Text] [Related]
7. Protein substitutes for phenylketonuria in Europe: access and nutritional composition.
Pena MJ; de Almeida MF; van Dam E; Ahring K; Bélanger-Quintana A; Dokoupil K; Gokmen-Ozel H; Lammardo AM; MacDonald A; Robert M; Rocha JC
Eur J Clin Nutr; 2016 Jul; 70(7):785-9. PubMed ID: 27117930
[TBL] [Abstract][Full Text] [Related]
8. Dietary protein and protein substitute requirements in adults with phenylketonuria: A review of the clinical guidelines.
Firman S; Witard OC; O'Keeffe M; Ramachandran R
Clin Nutr; 2021 Mar; 40(3):702-709. PubMed ID: 33308842
[TBL] [Abstract][Full Text] [Related]
9. Advances in the nutritional and pharmacological management of phenylketonuria.
Ney DM; Blank RD; Hansen KE
Curr Opin Clin Nutr Metab Care; 2014 Jan; 17(1):61-8. PubMed ID: 24136088
[TBL] [Abstract][Full Text] [Related]
10. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
[TBL] [Abstract][Full Text] [Related]
11. The Use of Glycomacropeptide in Patients with Phenylketonuria: A Systematic Review and Meta-Analysis.
Pena MJ; Pinto A; Daly A; MacDonald A; Azevedo L; Rocha JC; Borges N
Nutrients; 2018 Nov; 10(11):. PubMed ID: 30453665
[TBL] [Abstract][Full Text] [Related]
12. A Three-Year Longitudinal Study Comparing Bone Mass, Density, and Geometry Measured by DXA, pQCT, and Bone Turnover Markers in Children with PKU Taking L-Amino Acid or Glycomacropeptide Protein Substitutes.
Daly A; Högler W; Crabtree N; Shaw N; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; Strauss BJ; Wilcox G; Fraser WD; Tang JCY; MacDonald A
Nutrients; 2021 Jun; 13(6):. PubMed ID: 34204378
[TBL] [Abstract][Full Text] [Related]
13. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
[No Abstract] [Full Text] [Related]
14. Glycomacropeptide in children with phenylketonuria: does its phenylalanine content affect blood phenylalanine control?
Daly A; Evans S; Chahal S; Santra S; MacDonald A
J Hum Nutr Diet; 2017 Aug; 30(4):515-523. PubMed ID: 28111827
[TBL] [Abstract][Full Text] [Related]
15. Glycomacropeptide in PKU-Does It Live Up to Its Potential?
Daly A; Pinto A; Evans S; MacDonald A
Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215457
[TBL] [Abstract][Full Text] [Related]
16. Casein glycomacropeptide in phenylketonuria: does it bring clinical benefit?
Daly A; Ilgaz F; Pinto A; MacDonald A
Curr Opin Clin Nutr Metab Care; 2024 Jan; 27(1):31-39. PubMed ID: 38085662
[TBL] [Abstract][Full Text] [Related]
17. The Impact of the Use of Glycomacropeptide on Satiety and Dietary Intake in Phenylketonuria.
Daly A; Evans S; Pinto A; Jackson R; Ashmore C; Rocha JC; MacDonald A
Nutrients; 2020 Sep; 12(9):. PubMed ID: 32899700
[TBL] [Abstract][Full Text] [Related]
18. Plasma amino acids in adolescents and adults with phenylketonuria on three different levels of protein intake.
Clemens PC; Heddrich-Ellerbrok M; Wachtel V; Link RM
Acta Paediatr Scand; 1991 May; 80(5):577-80. PubMed ID: 1872187
[No Abstract] [Full Text] [Related]
19. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
[TBL] [Abstract][Full Text] [Related]
20. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
